PBH · Annual Report (Form 10-K) · Filed May 14, 2026

Prestige Consumer Healthcare Inc — 10-K exhibit

exhibit211directindirectsu.htm

Prestige Consumer Healthcare Inc on Boardroom Alpha

Document

Exhibit 21.1

SUBSIDIARIES LIST

Direct and Indirect Subsidiaries

of Prestige Consumer Healthcare Inc.


Name_________________________			Jurisdiction of Incorporated/Organization


Blacksmith Brands, Inc.			Delaware
Briemar Nominees Pty Ltd.			Australia
C.B. Fleet Company, Incorporated			Virginia
C.B. Fleet Investment Corporation			Delaware
C.B. Fleet International LLC (formerly C.B. Fleet, International, Inc.)			Virginia
C.B. Fleet International(s) Pte. Ltd			Singapore
Care Acquisition Company Pty Limited			Australia
Care Pharmaceuticals Pty Limited			Australia
Cellegy Australia Pty			Australia
Clear Eyes Pharma Limited			England and Wales
DenTek Holdings, Inc.			Delaware
DenTek Oral Care, Inc.			Tennessee
DenTek Oral Care Limited			England and Wales
Insight Pharmaceuticals Corporation			Delaware
Insight Pharmaceuticals LLC			Delaware
Medtech Holdings, Inc.			Delaware
Medtech Online Inc.			Delaware
Medtech Personal Products Corporation			Delaware
Medtech Products Inc.			Delaware
PBH Australia Holdings Company Pty Limited			Australia
Pakaging Innovations Pty Ltd.			Australia
Peaks HBC Company, Inc.			Virginia
Pillar5Pharma Inc.			Canada
Practical Health Products, Inc			Delaware
Prestige Brands Holdings, Inc.			Virginia
Prestige Brands, Inc.			Delaware
Prestige Brands Gmbh			Germany
Prestige Brands International, Inc.			Virginia
Prestige Brands (UK) Limited			England and Wales
Prestige Brands SPE Lender, LLC			Delaware
Prestige Services Corp.			Delaware
The Spic and Span Company			Delaware
Wartner USA B.V.			Netherlands

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer